Related Experiment Video
Updated: Dec 12, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Histologic parameter score does not predict short-term survival in severe alcoholic hepatitis
Margaux Dubois1, Amedeo Sciarra2, Eric Trépo3,4
1Division of Gastroenterology and Hepatology, University of Lausanne, Lausanne, Switzerland.
The alcoholic hepatitis histologic score does not predict short-term survival in severe alcoholic hepatitis patients. Further research is needed to refine prognostic tools for this condition.
Area of Science:
- Hepatology
- Prognostic Biomarkers
- Liver Disease Histopathology
Background:
- Alcoholic hepatitis is a severe liver condition with high mortality.
- Accurate prognostic tools are crucial for managing patients with severe alcoholic hepatitis.
- The alcoholic hepatitis histologic score (AHHS) was proposed as a novel prognostic indicator.
Purpose of the Study:
- To evaluate the prognostic value of the AHHS in patients with severe alcoholic hepatitis.
- To assess the association between AHHS and short-term mortality.
- To compare the prognostic utility of AHHS with the Laennec staging system.
Main Methods:
- Retrospective analysis of liver biopsies from 107 patients with severe alcoholic hepatitis.
- Independent assessment of biopsies using the AHHS by two pathologists.
- Evaluation of fibrosis using the Laennec staging system.
- Survival analysis adjusted for age and MELD score.
Main Results:
- The AHHS showed good interobserver reproducibility for fibrosis assessment (κ=1.00).
- No significant association was found between AHHS categories (mild, moderate, severe) and 28-day, 3-month, or 6-month survival rates.
- Laennec stage was also not significantly associated with 6-month mortality in multivariate analysis.
Conclusions:
- The AHHS is not predictive of short-term survival in patients with severe alcoholic hepatitis.
- Current prognostic models may require refinement for this specific patient population.
- Further investigation into more robust prognostic markers is warranted.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

